We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

Giving Kids a Voice: How Patient-Reported Outcome Measures are Transforming Pediatric Specialty Care

MedXY Editorial Team•Feb 25, 2026•news
clinical trialhealth communicationpatient-reported outcomesPediatrics

The Gap Between Clinical Metrics and Lived Experience

In the busy world of pediatric specialty clinics—where the focus often narrows to lung function, bowel movements, or sleep cycles—there is a quiet but significant risk of missing the ‘big picture.’ For decades, medical success has been measured through objective clinical markers: the results of a blood test, the sound of a heartbeat, or the clear imaging of a joint. While these are essential, they often fail to capture how a child actually feels or how their condition affects their daily life. This disconnect is what patient-reported outcome measures (PROMs) aim to fix.

Meet the Millers: A Case for Better Communication

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Evaluating Cusatuzumab Combined with Venetoclax ± Azacitidine in Unfit Newly Diagnosed AML: Insights from the Phase Ib ELEVATE TrialThe phase Ib ELEVATE study demonstrates that cusatuzumab combined with venetoclax and azacitidine offers a promising tolerable and effective frontline therapy for patients with newly diagnosed acute myeloid leukemia ineligible for intensiveSep 9, 2026VRONI Study: Advancing Pediatric Genetic Screening for Familial Hypercholesterolaemia to Improve Early Cardiovascular HealthThe VRONI study demonstrates the feasibility and effectiveness of combined biochemical and genetic screening for familial hypercholesterolaemia (FH) in children, revealing a higher FH prevalence than previously reported and supporting natioSep 5, 2026Therapeutic Hypothermia at 35°C vs. Controlled Normothermia in ICU Heatstroke: Insights from a Pilot RCTA pilot randomized trial comparing targeted temperature management at 35°C versus normothermia in intubated heatstroke patients showed no survival or neurological benefit from hypothermia but increased gastrointestinal injury and arrhythmiaSep 3, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Gabapentin for Cough in Idiopathic Pulmonary Fibrosis: Efficacy and Safety Insights from a Randomized Controlled Trial
A randomized, double-blind, placebo-controlled trial demonstrates gabapentin’s significant efficacy and acceptable safety for treating cough in IPF, supporting its clinical use amid limited alternatives.
Sep 1, 2026
Patient Perspectives on Prolactinoma in Females: Insights from the Dutch Cohort StudiesA large Dutch cohort study reveals fatigue and cognitive impairment as predominant symptoms in females with prolactinoma, with active disease linked to higher psychological burden despite dopamine agonist treatment.Sep 1, 2026
Oncoplastic Reconstruction Versus Reduction Mammoplasty in Macromastia: Safety, Satisfaction, and Aesthetic Outcomes ComparedOncoplastic breast reconstruction (OP) offers comparable safety and aesthetic results to bilateral breast reduction (BBR) while improving quality of life in women undergoing lumpectomy for macromastia.Aug 26, 2026